To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TMEM170AandCFDP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
545 supporting clones for gene TMEM170AandCFDP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BY796394 eye .a 1 to 530 1 to 530   tiling clone,   530/530
(100 %)
0 diff
(100 %id)
BG180967 adenocarcinoma, cell line, Prostate .a 19 to 137 1 to 118       118/118
(100 %)
1 diff
(99.2 %id)
CB112913 Liver .a 24 to 135 1 to 112       112/112
(100 %)
2 diff
(98.3 %id)
DB246183 uterus, tumor tissue .a 25 to 289 2 to 266   capped   265/265
(100 %)
1 diff
(99.7 %id)
CD522293 pooled .a 335 to 1028 1 to 704   tiling clone,   704/739
(95 %)
25 diff
(96.7 %id)
CN354890 embryonic stem cells, DMSO-treated H9 cellline .b 1 to 634 1 to 634   tiling clone,   634/634
(100 %)
0 diff
(100 %id)
DW438185 Liver .b 15 to 232 18 to 236       219/246
(89 %)
3 diff
(98.8 %id)
BU943118 mixed (pool of 40 RNAs) .b 18 to 555 1 to 545       545/867
(62 %)
33 diff
(96.2 %id)
DW458537 Liver .b 23 to 159 18 to 154       137/154
(88 %)
6 diff
(96.2 %id)
DW466340 Liver .b 24 to 360 18 to 352       335/352
(95 %)
9 diff
(97.5 %id)
AW160432 brain, frontal lobe .b 25 to 669 1 to 645     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 645/645
(100 %)
9 diff
(98.7 %id)
CD708953 normal nasopharynx .b 27 to 263 36 to 271       236/271
(87 %)
6 diff
(97.8 %id)
CN354889 embryonic stem cells, cell lines H1, H7, andH9 .b 27 to 693 1 to 666       666/666
(100 %)
4 diff
(99.4 %id)
DW432514 Liver .b 27 to 274 18 to 265       248/265
(93 %)
10 diff
(96.3 %id)
DW452299 Liver .b 27 to 200 19 to 192       174/193
(90 %)
1 diff
(99.5 %id)
NM_006324.2   .b 29 to 1309 1 to 1281 exact RefSeq,   1281/1281
(100 %)
2 diff
(99.9 %id)
BF969756 adrenal cortex carcinoma, cell line, adrenal gland .b 30 to 812 1 to 776       776/776
(100 %)
17 diff
(97.9 %id)
BI545489 brain, hippocampus .b 32 to 689 1 to 663       661/663
(99 %)
20 diff
(97.0 %id)
BC000991 Placenta, choriocarcinoma .b 33 to 1306 1 to 1274 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 1274/1274
(100 %)
1 diff
(100.0 %id)
CN354886 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 33 to 748 13 to 728       716/728
(98 %)
7 diff
(99.1 %id)
CN354888 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 33 to 729 1 to 697       697/697
(100 %)
0 diff
(100 %id)
TI_57199133   .b 34 to 817 70 to 852       783/863
(90 %)
13 diff
(98.5 %id)
CD709896 normal nasopharynx .b 35 to 264 31 to 260       230/260
(88 %)
7 diff
(97.4 %id)
BI822302 pooled brain, lung, testis .b 35 to 817 1 to 782       782/793
(98 %)
7 diff
(99.2 %id)
CR623318 adult brain .b 36 to 1288 1 to 1253 exact     1253/1253
(100 %)
0 diff
(100 %id)
AL533372 adult brain, brain .b 36 to 577 1 to 547       547/676
(80 %)
12 diff
(98.3 %id)
BX411532 adult brain, brain .b 36 to 737 702 to 1       702/702
(100 %)
3 diff
(99.6 %id)
BU165784 leiomyosarcoma, uterus .b 37 to 816 1 to 780       780/902
(86 %)
5 diff
(99.5 %id)
BU195487 leiomyosarcoma, uterus .b 37 to 801 1 to 774       774/896
(86 %)
15 diff
(98.4 %id)
CB149286 Liver .b 37 to 599 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
AW161222 brain, frontal lobe .b 39 to 617 1 to 580     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 580/580
(100 %)
8 diff
(98.7 %id)
BU955738 mixed (pool of 40 RNAs) .b 39 to 644 1 to 605       607/609
(99 %)
11 diff
(98.2 %id)
TI_44165567   .b 39 to 689 129 to 784       654/784
(83 %)
21 diff
(97.4 %id)
ES313339 beard hair, skin .b 40 to 617 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
FN154238 breast carcinoma .b 40 to 145 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
CX782053 human embryonic stem cells .b 41 to 896 1 to 856       856/856
(100 %)
3 diff
(99.7 %id)
BU596146 mixed (pool of 40 RNAs) .b 42 to 635 1 to 602       600/848
(70 %)
18 diff
(97.9 %id)
BX478800   .b 45 to 483 10 to 449       440/449
(97 %)
6 diff
(98.7 %id)
BU933700 mixed (pool of 40 RNAs) .b 45 to 678 1 to 636       636/840
(75 %)
12 diff
(98.6 %id)
CX754868 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 45 to 767 1 to 722     Submitted on the opposite strand 722/724
(99 %)
7 diff
(99.1 %id)
AA313647 colon .b 46 to 567 1 to 522       522/525
(99 %)
2 diff
(99.7 %id)
AA323728 brain, cerebellum .b 46 to 370 1 to 325       325/325
(100 %)
1 diff
(99.7 %id)
BF212182 bone marrow, from chronic myelogenous leukemia .b 46 to 667 1 to 625       625/839
(74 %)
36 diff
(95.8 %id)
DR762984 embryonic stem .b 46 to 738 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
DA959702 Spleen .b 46 to 617 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AW952328   .b 47 to 571 1 to 525   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 525/659
(79 %)
4 diff
(99.4 %id)
BG685734 B-cells, primary B-cells from tonsils (cell line) .b 47 to 572 1 to 527       527/679
(77 %)
8 diff
(98.9 %id)
BE439446 Trabecular meshwork .b 48 to 698 1 to 647       647/650
(99 %)
13 diff
(98.0 %id)
CD685623 normal nasopharynx .b 48 to 567 23 to 540       518/540
(95 %)
8 diff
(98.6 %id)
CD688839 normal nasopharynx .b 48 to 560 42 to 554       513/554
(92 %)
8 diff
(98.6 %id)
CD695864 normal nasopharynx .b 48 to 647 23 to 622       600/622
(96 %)
7 diff
(98.9 %id)
DW410316 Liver .b 48 to 310 18 to 280   AAA   263/280
(93 %)
6 diff
(97.9 %id)
DW440167 Liver .b 48 to 269 18 to 239       222/239
(92 %)
7 diff
(97.1 %id)
DW444597 Liver .b 48 to 254 18 to 224       207/225
(92 %)
7 diff
(96.9 %id)
DW455643 Liver .b 48 to 203 18 to 173       156/173
(90 %)
6 diff
(96.6 %id)
BI826802 brain, medulla .b 48 to 634 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BI766146 pooled lung and spleen .b 48 to 803 1 to 753       753/754
(99 %)
8 diff
(99.0 %id)
BI914553 brain .b 48 to 686 1 to 639       639/639
(100 %)
3 diff
(99.6 %id)
CV808004 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 48 to 817 1 to 774       774/875
(88 %)
10 diff
(98.9 %id)
CX762910 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 48 to 768 1 to 712       712/889
(80 %)
12 diff
(98.7 %id)
CX757036 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 48 to 698 1 to 649       649/857
(75 %)
11 diff
(98.8 %id)
TI_57241585   .b 48 to 686 30 to 668       639/668
(95 %)
6 diff
(99.2 %id)
TI_57177929   .b 49 to 803 33 to 784       752/785
(95 %)
10 diff
(98.8 %id)
TI_57174414   .b 49 to 634 31 to 615       585/615
(95 %)
11 diff
(98.3 %id)
CX762575 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 50 to 743 1 to 694     Submitted on the opposite strand 694/694
(100 %)
0 diff
(100 %id)
BU959225 mixed (pool of 40 RNAs) .b 52 to 803 1 to 762       762/850
(89 %)
27 diff
(96.9 %id)
BE537080 cervix .b 55 to 796 1 to 745       745/749
(99 %)
43 diff
(94.3 %id)
BE740297 adenocarcinoma cell line, ovary .b 55 to 817 1 to 757       757/776
(97 %)
10 diff
(98.8 %id)
AB009285   .b 57 to 1300 1 to 1244 exact     1244/1244
(100 %)
1 diff
(100.0 %id)
DT220046 brain .b 58 to 290 1 to 233       233/233
(100 %)
5 diff
(97.9 %id)
BM556249 amelanotic melanoma, cell line, skin .b 60 to 817 1 to 757       757/1105
(68 %)
2 diff
(99.9 %id)
BM562105 amelanotic melanoma, cell line, skin .b 60 to 817 1 to 759       759/1063
(71 %)
6 diff
(99.5 %id)
BM424006 amelanotic melanoma, cell line, skin .b 60 to 817 1 to 757       757/1031
(73 %)
3 diff
(99.8 %id)
BP372161 umbilical cord .b 60 to 641 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM810700 amelanotic melanoma, cell line, skin .b 61 to 817 1 to 758       758/1083
(69 %)
7 diff
(99.4 %id)
BM810721 amelanotic melanoma, cell line, skin .b 61 to 816 1 to 757       757/1092
(69 %)
2 diff
(99.9 %id)
BQ673867 epidermoid carcinoma, cell line, salivary gland .b 61 to 672 1 to 614       614/989
(62 %)
17 diff
(98.3 %id)
BQ675826 epidermoid carcinoma, cell line, salivary gland .b 61 to 892 1 to 838       838/839
(99 %)
8 diff
(99.1 %id)
CR626586 fetal brain .b 64 to 1298 1 to 1235 exact     1235/1235
(100 %)
0 diff
(100 %id)
BX461142 brain, fetal brain .b 64 to 977 1 to 911   fully sequenced,   911/911
(100 %)
5 diff
(99.5 %id)
TI_57174336   .b 65 to 885 25 to 842       818/842
(97 %)
13 diff
(98.5 %id)
CK003379 brain/CNS, Human Brain - Cerebellar Cortex .b 67 to 725 1 to 657       657/657
(100 %)
6 diff
(99.1 %id)
BU661113 blood .b 70 to 567 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
BX370324   .b 71 to 789 1 to 722       722/790
(91 %)
24 diff
(97.0 %id)
BI826924 brain, medulla .b 72 to 885 1 to 811       811/811
(100 %)
7 diff
(99.2 %id)
BQ581839 insulinoma, Pancreas .b 72 to 666 8 to 602     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 595/602
(98 %)
7 diff
(98.9 %id)
BQ921307 leiomyosarcoma, uterus .b 73 to 950 1 to 883       883/883
(100 %)
9 diff
(99.0 %id)
CN354887 embryonic stem cells, cell lines H1, H7, andH9 .b 78 to 805 1 to 728       728/728
(100 %)
3 diff
(99.6 %id)
BX404382 neuroblastoma .b 79 to 726 1 to 649   fully sequenced,   649/649
(100 %)
2 diff
(99.7 %id)
CR622718 neuroblastoma .b 79 to 1285 1 to 1207 exact     1207/1207
(100 %)
0 diff
(100 %id)
AV748209 Pituitary .b 82 to 254 1 to 172       172/176
(97 %)
4 diff
(97.8 %id)
AK313948 skeletal muscle .b 87 to 1065 1 to 979 V176L     979/979
(100 %)
2 diff
(99.8 %id)
DA897279 skeletal muscle .b 88 to 655 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BE696546 colon .b 91 to 554 469 to 6       464/469
(98 %)
1 diff
(99.8 %id)
CN354891 embryonic stem cells, DMSO-treated H9 cellline .b 91 to 501 1 to 412       412/412
(100 %)
2 diff
(99.6 %id)
BU662798 blood .b 94 to 770 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BE779915 eye, retinoblastoma .b 94 to 779 1 to 676       676/962
(70 %)
12 diff
(98.8 %id)
AA252713   .b 119 to 316 1 to 199       199/199
(100 %)
6 diff
(97.0 %id)
DR432885 mixed .b 161 to 598 1 to 438   fully sequenced,   438/438
(100 %)
4 diff
(99.1 %id)
DR432865 mixed .b 161 to 647 1 to 487   fully sequenced,   487/487
(100 %)
4 diff
(99.2 %id)
DR433012 mixed .b 161 to 726 1 to 566   fully sequenced,   566/566
(100 %)
4 diff
(99.3 %id)
DR432807 mixed .b 161 to 726 1 to 566   fully sequenced,   566/566
(100 %)
5 diff
(99.2 %id)
DR432438 mixed .b 161 to 647 1 to 487   fully sequenced,   487/487
(100 %)
4 diff
(99.2 %id)
FN078291 breast carcinoma .b 164 to 271 1 to 108       108/108
(100 %)
0 diff
(100 %id)
TI_1948103755   .b 165 to 817 133 to 787       655/1336
(49 %)
10 diff
(99.3 %id)
TI_1948103886   .b 165 to 726 130 to 693   fully sequenced,   564/693
(81 %)
6 diff
(99.2 %id)
BT009819   .b 166 to 1063 1 to 898       898/900
(99 %)
2 diff
(99.8 %id)
CR542111   .b 166 to 1065 1 to 900 exact     900/900
(100 %)
0 diff
(100 %id)
CV023882 mixed .b 166 to 790 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
TI_1948103491   .b 166 to 696 129 to 663       535/1221
(43 %)
34 diff
(97.3 %id)
DR979711 placenta .b 174 to 315 8 to 148   AAA Submitted on the opposite strand 141/148
(95 %)
6 diff
(96.0 %id)
AI460026 brain, meningioma .b 184 to 629 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AI908458 breast .b 220 to 704 510 to 25       486/541
(89 %)
7 diff
(98.8 %id)
TI_149309778   .b 226 to 765 615 to 75   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 541/1066
(50 %)
10 diff
(99.1 %id)
D86549   .b 237 to 1299 8 to 1070       1063/1072
(99 %)
9 diff
(99.2 %id)
BU688146 lung .b 277 to 765 496 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 489/496
(98 %)
2 diff
(99.6 %id)
CR989399 T-Lymphocytes .b 292 to 1109 1 to 818       818/818
(100 %)
2 diff
(99.8 %id)
FN173284 breast carcinoma .b 305 to 416 1 to 110       110/111
(99 %)
6 diff
(94.6 %id)
BM698538 eye, fetal eyes .b 307 to 450 1 to 144     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 144/144
(100 %)
0 diff
(100 %id)
CN354892 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 311 to 883 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BG032863 breast, mammary adenocarcinoma, cell line .b 320 to 1059 1 to 747   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 747/750
(99 %)
17 diff
(97.8 %id)
BG031314 breast, mammary adenocarcinoma, cell line .b 357 to 1200 1 to 842       842/884
(95 %)
34 diff
(96.2 %id)
CD710677 normal nasopharynx .b 364 to 924 35 to 595       561/595
(94 %)
6 diff
(99.0 %id)
TI_149309723   .b 365 to 1306 1012 to 86   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 926/958
(96 %)
24 diff
(97.5 %id)
BF747129 breast .b 366 to 567 2 to 203       202/206
(98 %)
7 diff
(96.7 %id)
BF330829 breast .b 367 to 567 211 to 11       201/211
(95 %)
0 diff
(100 %id)
TI_149305297   .b 383 to 1289 985 to 90   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 896/950
(94 %)
25 diff
(97.4 %id)
DR432687 mixed .b 388 to 1064 682 to 6       677/682
(99 %)
1 diff
(99.9 %id)
BM853703 Ascites, stomach .b 391 to 665 1 to 275       275/275
(100 %)
0 diff
(100 %id)
BE772752 prostate_tumor .b 393 to 577 187 to 4       184/187
(98 %)
0 diff
(100 %id)
BG028376 Bone, osteosarcoma, cell line .b 413 to 1179 1 to 763       763/970
(78 %)
20 diff
(98.0 %id)
BM693143 eye, Retina Foveal and Macular .b 431 to 799 1 to 371     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 371/371
(100 %)
1 diff
(99.8 %id)
TI_149290708   .b 435 to 1306 937 to 84   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 854/952
(89 %)
62 diff
(93.5 %id)
BF155358 head_neck .b 444 to 1044 1 to 599       599/599
(100 %)
32 diff
(94.7 %id)
TI_149312743   .b 456 to 1300 928 to 88   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 841/1004
(83 %)
10 diff
(99.1 %id)
TI_154106412   .b 456 to 1300 905 to 62   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 844/963
(87 %)
12 diff
(98.8 %id)
TI_157611094   .b 488 to 1281 880 to 88   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 793/794
(99 %)
11 diff
(98.7 %id)
AA046971 uterus .b 499 to 767 1 to 269       269/272
(98 %)
4 diff
(98.6 %id)
BM705327 eye, RPE and Choroid .b 512 to 1104 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BU685668 lung, Primary Lung Epithelial Cells .b 516 to 1289 792 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 774/774
(100 %)
7 diff
(99.1 %id)
TI_149290555   .b 524 to 1300 851 to 83   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 769/959
(80 %)
14 diff
(98.6 %id)
AA319873 adrenal gland .b 537 to 812 1 to 276       276/276
(100 %)
1 diff
(99.7 %id)
AA280382 germinal center B cell .b 537 to 696 1 to 161       161/163
(98 %)
6 diff
(96.4 %id)
DR432890 mixed .b 537 to 1064 533 to 6   fully sequenced,   528/533
(99 %)
0 diff
(100 %id)
BG109350 Bone, osteosarcoma, cell line .b 554 to 1310 1 to 755       755/923
(81 %)
24 diff
(97.4 %id)
TI_154131004   .b 562 to 1300 831 to 94   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 738/990
(74 %)
6 diff
(99.4 %id)
BU688100 lung .b 580 to 1306 744 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 726/726
(100 %)
1 diff
(99.9 %id)
BU609054 Human Lung Epithelial cells, lung .b 585 to 1306 740 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 722/722
(100 %)
3 diff
(99.6 %id)
TI_149281862   .b 592 to 1300 793 to 87   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 707/708
(99 %)
6 diff
(99.2 %id)
H21780 breast .b 593 to 895 1 to 304   fully sequenced,   304/304
(100 %)
0 diff
(100 %id)
CD702880 normal nasopharynx .b 596 to 977 21 to 402       382/417
(91 %)
10 diff
(97.7 %id)
TI_149291794   .b 613 to 1306 755 to 66   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 690/690
(100 %)
4 diff
(99.5 %id)
AA382805 testis .b 615 to 966 1 to 353       353/353
(100 %)
4 diff
(98.9 %id)
W94708 heart .b 616 to 1069 1 to 454   fully sequenced,   454/454
(100 %)
1 diff
(99.8 %id)
W69256 heart .b 617 to 931 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
AA476656   .b 617 to 1005 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
DR432866 mixed .b 617 to 1064 453 to 6   fully sequenced,   448/453
(98 %)
0 diff
(100 %id)
DR432433 mixed .b 617 to 1064 453 to 6   fully sequenced,   448/453
(98 %)
0 diff
(100 %id)
AW665414 pooled .b 622 to 1300 679 to 1       679/679
(100 %)
6 diff
(99.2 %id)
CD239238 Pituitary .b 625 to 1304 1 to 680   AAA   680/686
(99 %)
3 diff
(99.6 %id)
BU682201 lung .b 636 to 1306 685 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 667/667
(100 %)
4 diff
(99.5 %id)
BM978293 lung .b 641 to 1300 679 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 661/661
(100 %)
2 diff
(99.7 %id)
CA423098 cell lines, Chondrosarcoma .b 643 to 1306 682 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
TI_149276571   .b 644 to 1306 747 to 87   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 661/888
(74 %)
7 diff
(99.3 %id)
BU607966 Human Lung Epithelial cells, lung .b 646 to 1306 680 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 662/674
(98 %)
4 diff
(99.5 %id)
BU631990 cell lines, Chondrosarcoma .b 647 to 1306 679 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 661/661
(100 %)
3 diff
(99.6 %id)
BM989687 lung, Metastatic Chondrosarcoma .b 653 to 1306 669 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 651/659
(98 %)
4 diff
(99.4 %id)
AW341538 pooled .b 664 to 1301 638 to 1       638/641
(99 %)
2 diff
(99.7 %id)
AW341605 pooled .b 664 to 1301 638 to 1       638/638
(100 %)
11 diff
(98.3 %id)
BX454120 neuroblastoma .b 665 to 1281 620 to 6   fully sequenced,   615/620
(99 %)
0 diff
(100 %id)
DR433014 mixed .b 665 to 1064 405 to 6   fully sequenced,   400/405
(98 %)
0 diff
(100 %id)
DR432813 mixed .b 665 to 1064 405 to 6   fully sequenced,   400/405
(98 %)
0 diff
(100 %id)
TI_1948103887   .b 665 to 1064 529 to 126   fully sequenced,   404/529
(76 %)
3 diff
(99.5 %id)
AL527800 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 667 to 1307 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BQ581520 insulinoma, Pancreas .b 670 to 1306 652 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
BM702819 eye, Retina Foveal and Macular .b 674 to 1150 1 to 477   fully sequenced, Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 477/477
(100 %)
1 diff
(99.8 %id)
BQ021267 lung, Metastatic Chondrosarcoma .b 679 to 1281 621 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 603/603
(100 %)
1 diff
(99.9 %id)
BM990136 lung, Metastatic Chondrosarcoma .b 679 to 1300 640 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 622/622
(100 %)
1 diff
(99.9 %id)
BQ001594 lung, Metastatic Chondrosarcoma .b 679 to 1306 646 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 628/628
(100 %)
1 diff
(99.9 %id)
BM973671 lung .b 679 to 1306 646 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 628/628
(100 %)
1 diff
(99.9 %id)
CA418010 Bone, Human Chondrosarcoma Cell Line .b 679 to 1300 640 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
AA902651 pooled germ cell tumors .b 694 to 1281 589 to 2       588/632
(93 %)
7 diff
(98.9 %id)
BU677266 lung, Primary Lung Epithelial Cells .b 694 to 1306 630 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 612/622
(98 %)
2 diff
(99.7 %id)
BM983558 lung .b 694 to 1300 623 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 605/615
(98 %)
3 diff
(99.6 %id)
BM973534 lung .b 694 to 1300 624 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 606/616
(98 %)
2 diff
(99.7 %id)
BF036663 adenocarcinoma, ovary .b 728 to 1301 1 to 573       573/573
(100 %)
5 diff
(99.2 %id)
CA941205 Pancreas, Purified pancreatic islet .b 742 to 1305 564 to 1       564/564
(100 %)
5 diff
(99.2 %id)
BM662862 eye, Retina Foveal and Macular .b 750 to 1306 573 to 17   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 557/557
(100 %)
4 diff
(99.3 %id)
BM994426 lung, Metastatic Chondrosarcoma .b 754 to 1302 561 to 13       549/561
(97 %)
2 diff
(99.7 %id)
BU537670 mixed (pool of 40 RNAs) .b 757 to 1304 1 to 552       552/793
(69 %)
7 diff
(99.2 %id)
AI028099 parathyroid gland, parathyroid tumor .b 763 to 1306 559 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 544/544
(100 %)
5 diff
(99.1 %id)
BP383176 ilea mucosa .b 770 to 1312 1 to 541       541/600
(90 %)
8 diff
(98.7 %id)
AA777415 liver and spleen .b 780 to 1306 526 to 1       526/526
(100 %)
4 diff
(99.3 %id)
BG214945   .b 814 to 1271 470 to 14     Submitted on the opposite strand 457/479
(95 %)
0 diff
(100 %id)
AL533550 adult brain, brain .b 815 to 1288 472 to 1       472/607
(77 %)
4 diff
(99.4 %id)
AA775626 heart .b 815 to 1300 504 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 486/502
(96 %)
2 diff
(99.7 %id)
AA639857 colon, colon tumor RER+ .b 815 to 1300 488 to 1       488/491
(99 %)
12 diff
(97.6 %id)
AA904497 pooled .b 815 to 1060 247 to 1       247/334
(73 %)
3 diff
(99.2 %id)
AI016570   .b 815 to 1307 498 to 7       492/520
(94 %)
1 diff
(99.9 %id)
AI303015 2 pooled tumors (clear cell type), Kidney .b 815 to 1295 495 to 1       495/532
(93 %)
35 diff
(93.5 %id)
AI801398 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 815 to 1289 501 to 26   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 476/628
(75 %)
14 diff
(97.8 %id)
AW073975 2 pooled high-grade transitional celltumors, genitourinary tract .b 815 to 1290 474 to 1       474/571
(83 %)
4 diff
(99.3 %id)
AW161757 brain, frontal lobe .b 815 to 1306 502 to 11   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 492/628
(78 %)
2 diff
(99.7 %id)
AW162048 brain, frontal lobe .b 815 to 1306 502 to 11   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 492/654
(75 %)
5 diff
(99.3 %id)
BF063067 colon, colon tumor, RER+ .b 815 to 1281 475 to 9       467/476
(98 %)
5 diff
(99.0 %id)
CA941827 Pancreas, Purified pancreatic islet .b 815 to 1276 482 to 20       463/573
(80 %)
2 diff
(99.7 %id)
CA434980 lung, Metastatic Chondrosarcoma .b 815 to 1303 504 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 489/541
(90 %)
1 diff
(99.9 %id)
TI_151713450   .b 815 to 1282 592 to 125   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 468/742
(63 %)
2 diff
(99.8 %id)
CN354893 embryonic stem cells, cell lines H1, H7, andH9 .b 816 to 1306 7 to 496   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 490/496
(98 %)
6 diff
(98.8 %id)
N39726 melanocyte .b 816 to 924 92 to 200   fully sequenced,   109/200
(54 %)
0 diff
(100 %id)
N93785.
matches multiple genes
lung .b 816 to 1288 474 to 1     also hits gene CHD2 474/475
(99 %)
3 diff
(99.4 %id)
AI088487 uterus .b 816 to 1306 498 to 5       494/511
(96 %)
5 diff
(99.1 %id)
AI188585 placenta .b 817 to 1302 490 to 2       489/806
(60 %)
29 diff
(96.5 %id)
BG190600   .b 818 to 1268 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
BG213888   .b 818 to 1272 472 to 18     Submitted on the opposite strand 455/472
(96 %)
2 diff
(99.6 %id)
AI338815 lung .b 820 to 1301 482 to 1       482/538
(89 %)
1 diff
(99.9 %id)
AI829662 pooled .b 820 to 1301 482 to 1       482/690
(69 %)
1 diff
(99.9 %id)
AI624169 adenocarcinoma, Pancreas .b 821 to 1307 493 to 7       487/497
(97 %)
0 diff
(100 %id)
BI819538 pooled brain, lung, testis .b 821 to 1302 1 to 482       482/548
(87 %)
7 diff
(98.8 %id)
TI_57199394   .b 821 to 1302 28 to 509       482/806
(59 %)
13 diff
(98.4 %id)
CD579265 brain .b 832 to 1300 1 to 469   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 469/469
(100 %)
2 diff
(99.6 %id)
BM667459 eye, fetal eyes .b 835 to 1306 490 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
AA971627 carcinoid, lung .b 836 to 1060 225 to 1       225/226
(99 %)
8 diff
(96.5 %id)
AI376412   .b 838 to 1307 476 to 7       470/476
(98 %)
3 diff
(99.4 %id)
AI249180 liver and spleen .b 841 to 1307 471 to 5       467/471
(99 %)
6 diff
(98.8 %id)
AA553633 Schwannoma tumor .b 847 to 1299 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
AI040692 liver and spleen .b 847 to 1307 462 to 2       461/462
(99 %)
1 diff
(99.8 %id)
BE939160 testis_normal .b 848 to 1298 472 to 25       448/472
(94 %)
2 diff
(99.6 %id)
N68999 multiple sclerosis lesions .b 848 to 1280 434 to 2       433/434
(99 %)
0 diff
(100 %id)
AI370839   .b 851 to 1306 472 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 457/457
(100 %)
14 diff
(97.0 %id)
CB138750 Liver .b 852 to 1307 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
AA599711   .b 855 to 1307 455 to 2       454/457
(99 %)
1 diff
(99.8 %id)
AA865151 pooled germ cell tumors .b 857 to 1281 426 to 2       425/427
(99 %)
1 diff
(99.8 %id)
AI767820 2 pooled tumors (clear cell type), Kidney .b 857 to 1306 466 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 451/458
(98 %)
11 diff
(97.6 %id)
AA682613 liver and spleen .b 858 to 1300 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AV756368 bone marrow .b 859 to 1306 70 to 516   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 447/456
(98 %)
7 diff
(98.5 %id)
AA404328   .b 859 to 1302 447 to 4       444/447
(99 %)
0 diff
(100 %id)
AA813652   .b 865 to 1302 434 to 2       433/438
(98 %)
5 diff
(98.9 %id)
H21781 breast .b 865 to 1267 419 to 1   fully sequenced,   419/419
(100 %)
24 diff
(94.3 %id)
AI807758 pooled .b 869 to 1211 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
AA541248 colon .b 872 to 1306 435 to 1       435/435
(100 %)
1 diff
(99.8 %id)
AA047089 uterus .b 875 to 1281 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
BX401275.
matches multiple genes
  .b 880 to 1290 1 to 411     also hits gene PYCR2andLEFTY1 411/411
(100 %)
0 diff
(100 %id)
BY799867 eye .b 884 to 1307 1 to 424       424/424
(100 %)
0 diff
(100 %id)
N26631 melanocyte .b 894 to 1282 390 to 1   fully sequenced,   390/390
(100 %)
1 diff
(99.8 %id)
BP386849 pancreatic islet .b 899 to 1295 1 to 399     Submitted on the opposite strand 399/399
(100 %)
5 diff
(98.8 %id)
W69169 heart .b 901 to 1301 403 to 1   fully sequenced,   403/403
(100 %)
3 diff
(99.3 %id)
AI131536 heart .b 907 to 1306 401 to 1       401/401
(100 %)
5 diff
(98.8 %id)
AW629323 pooled .b 907 to 1302 397 to 2       396/397
(99 %)
0 diff
(100 %id)
AA974684 pooled .b 910 to 1280 371 to 1       371/371
(100 %)
1 diff
(99.8 %id)
BM467903 leiomyosarcoma, uterus .b 910 to 1287 32 to 407   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 376/407
(92 %)
11 diff
(97.3 %id)
AV717120   .b 911 to 1281 1 to 371       371/699
(53 %)
2 diff
(99.8 %id)
BE769416 prostate_tumor .b 912 to 1264 360 to 1       360/360
(100 %)
23 diff
(93.7 %id)
D79541 aorta .b 921 to 1279 20 to 378       359/379
(94 %)
14 diff
(96.4 %id)
AA834353 epithelium (cell line), Prostate .b 925 to 1285 361 to 1       361/361
(100 %)
1 diff
(99.8 %id)
AA191606   .b 930 to 1304 375 to 1       375/377
(99 %)
7 diff
(98.2 %id)
AA994892 pooled .b 931 to 1302 373 to 2       372/373
(99 %)
0 diff
(100 %id)
AW804854 uterus .b 934 to 1194 269 to 10       260/269
(96 %)
0 diff
(100 %id)
BM669009 eye, Retina Foveal and Macular .b 934 to 1306 392 to 20   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 373/373
(100 %)
3 diff
(99.2 %id)
AI005401   .b 936 to 1281 351 to 6       346/453
(76 %)
0 diff
(100 %id)
BX413466 brain, fetal brain .b 944 to 1298 358 to 2   fully sequenced,   357/358
(99 %)
10 diff
(97.3 %id)
AA446613   .b 944 to 1302 362 to 4   fully sequenced,   359/362
(99 %)
0 diff
(100 %id)
AI032908 liver and spleen .b 949 to 1307 359 to 1       359/359
(100 %)
2 diff
(99.5 %id)
AI270022 esophagus, squamous cell carcinoma .b 950 to 1301 352 to 1       352/353
(99 %)
9 diff
(97.5 %id)
AW800552 uterus .b 974 to 1292 321 to 1       321/346
(92 %)
9 diff
(97.4 %id)
AI219912 pooled .b 974 to 1281 309 to 2       308/488
(63 %)
0 diff
(100 %id)
AI458799 colon, moderately-differentiated adenocarcinoma .b 975 to 1280 332 to 29   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 304/304
(100 %)
5 diff
(98.4 %id)
EC564898 Prostate .b 979 to 1065 20 to 104       85/104
(81 %)
6 diff
(94.3 %id)
H88783 cochlea, ear .b 980 to 1301 326 to 1       326/417
(78 %)
5 diff
(98.9 %id)
CD104755 Pooled-Skin .b 998 to 1306 1 to 309   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 309/309
(100 %)
3 diff
(99.1 %id)
AW804853 uterus .b 1014 to 1189 176 to 1       176/176
(100 %)
0 diff
(100 %id)
W94625 heart .b 1039 to 1283 247 to 1   fully sequenced,   247/247
(100 %)
7 diff
(97.2 %id)
FN122754 breast carcinoma .b 1050 to 1149 100 to 1     Submitted on the opposite strand 100/102
(98 %)
2 diff
(98.1 %id)
AW237806 Kidney .b 1069 to 1307 240 to 2       239/240
(99 %)
0 diff
(100 %id)
AA470396 colon .b 1112 to 1295 184 to 1       184/184
(100 %)
0 diff
(100 %id)
BU729554 eye, Retina Foveal and Macular .b 1120 to 1306 205 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 187/187
(100 %)
0 diff
(100 %id)
AI802305   .b 1147 to 1281 135 to 1       135/135
(100 %)
0 diff
(100 %id)
H68716 liver and spleen .b 1152 to 1263 112 to 1       112/112
(100 %)
0 diff
(100 %id)
FN169855 breast carcinoma .b 1181 to 1298 1 to 117       117/117
(100 %)
1 diff
(99.2 %id)
BX473419   .c 1 to 852 1 to 855   tiling clone, to resequence,   855/856
(99 %)
5 diff
(99.5 %id)
BX473420   .c 1185 to 1798 614 to 1   tiling clone, to resequence,   614/614
(100 %)
6 diff
(99.1 %id)
BM554068 brain, medulla .d 1 to 1027 1 to 1033 exact tiling clone,   1033/1035
(99 %)
25 diff
(97.6 %id)
BX116092 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 737 to 1189 467 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
AI521056 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 871 to 1190 321 to 1   tiling clone,   321/321
(100 %)
1 diff
(99.7 %id)
D85939 placenta .e 1 to 1167 1 to 1167 exact tiling clone,   1167/1167
(100 %)
1 diff
(100.0 %id)
AA704968 liver and spleen .e 638 to 1167 529 to 1   tiling clone,   529/538
(98 %)
4 diff
(99.3 %id)
AA728885 breast, infiltrating ductal carcinoma .e 691 to 1006 315 to 1       315/329
(95 %)
5 diff
(98.5 %id)
AA715607 breast, infiltrating ductal carcinoma .e 691 to 1018 344 to 19       326/349
(93 %)
0 diff
(100 %id)
DN990857 brain, whole brain .f 1 to 607 10 to 616   tiling clone,   608/616
(98 %)
0 diff
(100 %id)
BX393099   .f 531 to 891 360 to 1   tiling clone,   360/360
(100 %)
8 diff
(97.8 %id)
CN299894 embryonic stem cells, cell lines H1, H7, andH9 .g 1 to 641 13 to 653 exact tiling clone,   641/653
(98 %)
7 diff
(99.0 %id)
DN999007 bone marrow .g 3 to 619 1 to 617 exact     617/617
(100 %)
7 diff
(98.9 %id)
AK311919   .g 11 to 543 1 to 533 exact     533/533
(100 %)
0 diff
(100 %id)
DA472437   .g 11 to 508 2 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
DA030856   .g 12 to 568 2 to 558 exact capped   557/557
(100 %)
0 diff
(100 %id)
CB960965 Human Placenta, placenta .g 16 to 639 26 to 655 exact     630/829
(75 %)
14 diff
(98.4 %id)
CD109662 Human Placenta, placenta .g 16 to 698 26 to 719 I140D L141F A142S T143Y L144S     694/776
(89 %)
22 diff
(97.2 %id)
BG714155 brain, hypothalamus .g 18 to 860 1 to 840 exact     840/874
(96 %)
14 diff
(98.4 %id)
BX503183 Liver .g 19 to 478 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
BC018082 Brain, hypothalamus .g 23 to 1074 1 to 1052 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1052/1052
(100 %)
2 diff
(99.9 %id)
BU154224 eye, retinoblastoma .g 23 to 877 1 to 861 exact     861/861
(100 %)
10 diff
(98.9 %id)
NM_145254.1   .g 23 to 1074 1 to 1052 exact RefSeq, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1052/1052
(100 %)
2 diff
(99.9 %id)
DB483641 hippocampus .g 28 to 471 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
TI_1948243399   .g 106 to 565 564 to 105 exact     460/642
(71 %)
1 diff
(99.9 %id)
TI_1948243719   .g 106 to 565 122 to 581 exact     460/616
(74 %)
19 diff
(97.0 %id)
TI_1948243879   .g 106 to 565 121 to 580 exact AAA   460/670
(68 %)
17 diff
(97.5 %id)
EL733116 mixed .g 109 to 542 1 to 434       434/602
(72 %)
2 diff
(99.7 %id)
BG215792   .g 234 to 1002 32 to 800       774/800
(96 %)
27 diff
(96.7 %id)
BG210062   .g 241 to 372 1 to 132       132/132
(100 %)
7 diff
(94.7 %id)
BG181930   .g 242 to 624 1 to 384       384/391
(98 %)
9 diff
(97.7 %id)
BG181931   .g 242 to 525 1 to 284       284/284
(100 %)
7 diff
(97.6 %id)
BG195450   .g 242 to 995 1 to 741       741/767
(96 %)
26 diff
(96.7 %id)
BG221361   .g 242 to 964 1 to 720       720/784
(91 %)
24 diff
(97.0 %id)
AA886733 carcinoid, lung .g 293 to 629 1 to 337     Submitted on the opposite strand 337/337
(100 %)
0 diff
(100 %id)
AI337404 colon, colon tumor, RER+ .g 293 to 769 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
CD522352 pooled .g 352 to 973 1 to 624   tiling clone,   624/731
(85 %)
12 diff
(98.4 %id)
BM474741 eye, retinoblastoma .g 362 to 933 32 to 605       574/1312
(43 %)
22 diff
(98.4 %id)
DB314789   .g 1905 to 2387 483 to 1   tiling clone,   483/483
(100 %)
3 diff
(99.4 %id)
BI599255 brain, hypothalamus .h -11 to 759 1 to 770 A15G L16A V17R H19S S21L ... tiling clone,   770/831
(92 %)
27 diff
(96.8 %id)
TI_45215038   .h 1 to 759 99 to 856 A15G L16A V17R H19S S21L ...     763/917
(83 %)
26 diff
(97.2 %id)
DB503496 hypothalamus .h 1 to 464 5 to 467 C68A S69P F70S P71Q E72R ...     467/467
(100 %)
1 diff
(99.8 %id)
DB505968 hypothalamus .h 1 to 502 5 to 505 C68A S69P F70S P71Q E72R ... tiling clone,   505/505
(100 %)
1 diff
(99.9 %id)
BQ931868 brain, neuroblastoma, cell line .h 11 to 751 1 to 749   tiling clone,   749/920
(81 %)
15 diff
(98.4 %id)
BG542630 lung .i 1 to 605 1 to 611 T48S K52H R53T K54E A55R ... tiling clone,   611/611
(100 %)
21 diff
(96.6 %id)
AK298475   .j 1 to 1549 1 to 1549 exact     1549/1549
(100 %)
2 diff
(99.9 %id)
BX647432 human colon endothel primary cell culture .j 1 to 4345 1 to 4346 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 4346/4346
(100 %)
12 diff
(99.8 %id)
DC428376   .j 1 to 578 1 to 578 exact     578/578
(100 %)
0 diff
(100 %id)
CD110112 placenta, pre-eclamptic placenta .k 1 to 569 29 to 601 T103H G104W Q105T T106D F107I ...     574/824
(69 %)
20 diff
(97.6 %id)
CB996719 placenta, pre-eclamptic placenta .k 1 to 701 29 to 734 exact tiling clone,   707/818
(86 %)
22 diff
(97.4 %id)
BX648484 human endometrium .k 47 to 4814 1 to 4766 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 4766/4766
(100 %)
16 diff
(99.7 %id)
BQ216102 large cell carcinoma, lung .k 62 to 615 1 to 564 exact AAA   564/756
(74 %)
15 diff
(98.1 %id)
AY302139   .k 137 to 502 1 to 366 exact     366/366
(100 %)
0 diff
(100 %id)
TI_154173998   .k 262 to 1016 847 to 90     Submitted on the opposite strand 758/1250
(60 %)
20 diff
(98.4 %id)
AW450509   .k 264 to 793 1 to 533     Submitted on the opposite strand 536/533
(100 %)
7 diff
(98.7 %id)
BG200558   .k 265 to 500 1 to 237       237/237
(100 %)
3 diff
(98.8 %id)
BG195451   .k 269 to 540 1 to 274       274/274
(100 %)
8 diff
(97.1 %id)
BG183484   .k 270 to 1080 1 to 805       805/805
(100 %)
19 diff
(97.7 %id)
BG189833   .k 270 to 1033 1 to 759       759/809
(93 %)
26 diff
(96.8 %id)
BG192358   .k 270 to 484 43 to 257       216/257
(84 %)
10 diff
(96.2 %id)
BG203648   .k 270 to 591 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
BG215224   .k 270 to 1032 1 to 759       759/780
(97 %)
36 diff
(95.4 %id)
AW028583 fibrotheoma, ovary .k 271 to 705 1 to 435     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
BE221507 carcinoid, lung .k 271 to 784 1 to 514     Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
BG194432   .k 281 to 603 1 to 325       325/325
(100 %)
8 diff
(97.6 %id)
BE670365 carcinoid, lung .k 289 to 796 1 to 509     Submitted on the opposite strand 509/509
(100 %)
2 diff
(99.7 %id)
BE670429 carcinoid, lung .k 289 to 802 1 to 514     Submitted on the opposite strand 514/514
(100 %)
3 diff
(99.5 %id)
BE671561 carcinoid, lung .k 289 to 585 1 to 298     Submitted on the opposite strand 298/298
(100 %)
3 diff
(99.0 %id)
BF446576 carcinoid, lung .k 289 to 804 1 to 517     Submitted on the opposite strand 517/517
(100 %)
4 diff
(99.3 %id)
BF447780 carcinoid, lung .k 289 to 793 1 to 505     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
AI640535 Kidney .k 290 to 754 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
N49836 multiple sclerosis lesions .k 295 to 928 633 to 1       633/638
(99 %)
9 diff
(98.6 %id)
AI589819 anaplastic oligodendroglioma, brain .k 295 to 742 1 to 448   tiling clone, Submitted on the opposite strand 448/459
(97 %)
1 diff
(99.8 %id)
AI214966 carcinoid, lung .k 321 to 708 1 to 388     Submitted on the opposite strand 388/390
(99 %)
5 diff
(98.8 %id)
AI690138 carcinoid, lung .k 321 to 796 1 to 476     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
AI694372 carcinoid, lung .k 321 to 792 1 to 472     Submitted on the opposite strand 472/472
(100 %)
1 diff
(99.8 %id)
AI702138 carcinoid, lung .k 321 to 619 1 to 298     Submitted on the opposite strand 298/298
(100 %)
8 diff
(97.4 %id)
AW418629 carcinoid, lung .k 321 to 807 1 to 487     Submitted on the opposite strand 487/487
(100 %)
1 diff
(99.8 %id)
BE219322 carcinoid, lung .k 321 to 815 1 to 495     Submitted on the opposite strand 495/495
(100 %)
1 diff
(99.8 %id)
BE328073 carcinoid, lung .k 321 to 763 1 to 443     Submitted on the opposite strand 443/443
(100 %)
4 diff
(99.1 %id)
AA932964 carcinoid, lung .k 323 to 827 1 to 506     Submitted on the opposite strand 506/506
(100 %)
5 diff
(99.1 %id)
AI917687 pooled germ cell tumors .k 323 to 497 1 to 175     Submitted on the opposite strand 175/175
(100 %)
0 diff
(100 %id)
EH322500   .k 402 to 480 1 to 79       79/86
(91 %)
4 diff
(95.4 %id)
BQ361177 ovary .k 409 to 769 382 to 24       359/384
(93 %)
0 diff
(100 %id)
AI554891 pooled .k 427 to 926 501 to 3       499/501
(99 %)
0 diff
(100 %id)
G36571   .k 429 to 928 500 to 1     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
AA622544 germ cell tumor .k 442 to 924 482 to 1       482/482
(100 %)
7 diff
(98.6 %id)
BF446700 carcinoid, lung .k 448 to 928 494 to 14   AAA   481/481
(100 %)
1 diff
(99.8 %id)
AI018223 pooled .k 452 to 926 476 to 3       474/476
(99 %)
0 diff
(100 %id)
DB574735 hypothalamus .k 453 to 925 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
BF594624 Kidney .k 484 to 928 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AL538300 brain, fetal brain .k 552 to 1404 1 to 853   tiling clone,   853/853
(100 %)
1 diff
(99.9 %id)
AI873438 pooled .k 552 to 931 381 to 1       381/381
(100 %)
2 diff
(99.5 %id)
AI632137 pooled germ cell tumors .k 563 to 928 377 to 12   AAA   366/366
(100 %)
1 diff
(99.8 %id)
DB577271 hypothalamus .k 573 to 925 1 to 353     Submitted on the opposite strand 353/353
(100 %)
2 diff
(99.5 %id)
AI992299 pooled germ cell tumors .k 575 to 930 364 to 9       356/364
(97 %)
0 diff
(100 %id)
FN145257 breast carcinoma .k 579 to 663 82 to 1     Submitted on the opposite strand 82/84
(97 %)
3 diff
(96.5 %id)
AW573250 pooled .k 631 to 1115 488 to 4       485/488
(99 %)
0 diff
(100 %id)
EC473437 Prostate .k 643 to 742 22 to 121       100/123
(81 %)
3 diff
(97.6 %id)
EC507314 Prostate .k 643 to 742 20 to 118       99/120
(82 %)
2 diff
(98.4 %id)
BI091706 cervix .k 760 to 1432 1 to 673       673/675
(99 %)
7 diff
(99.0 %id)
CN299893 embryonic stem cells, DMSO-treated H9 cellline .k 791 to 1441 1 to 655       655/655
(100 %)
5 diff
(99.3 %id)
AA649162 germinal center B cell .k 801 to 1190 20 to 410     Submitted on the opposite strand 391/410
(95 %)
6 diff
(98.6 %id)
CA950584 Pancreas, Purified pancreatic islet .k 802 to 1429 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BG528858 adenocarcinoma, Prostate .k 829 to 1602 1 to 776       776/776
(100 %)
19 diff
(97.6 %id)
BU431732 lymph .k 1069 to 1536 8 to 475       468/475
(98 %)
6 diff
(98.8 %id)
TI_154153693   .k 1069 to 1566 81 to 578       498/578
(86 %)
6 diff
(99.0 %id)
BG428430 Kidney .k 1125 to 1688 1 to 562       562/562
(100 %)
3 diff
(99.5 %id)
EC466311 Prostate .k 1195 to 1319 1 to 119       119/119
(100 %)
6 diff
(95.0 %id)
BX451571 brain, fetal brain .k 1265 to 1892 11 to 641   tiling clone,   631/727
(86 %)
12 diff
(98.4 %id)
BG288767 bladder, transitional cell papilloma, cell line .k 1434 to 2034 1 to 600       600/887
(67 %)
15 diff
(98.4 %id)
CN264112 embryonic stem cells, cell lines H1, H7, andH9 .k 1460 to 1855 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
AW971960   .k 1736 to 2360 732 to 112   tiling clone, Submitted on the opposite strand 621/732
(84 %)
0 diff
(100 %id)
BG290923 bladder, transitional cell papilloma, cell line .k 1792 to 2322 1 to 542       542/1016
(53 %)
38 diff
(96.3 %id)
AA528441 Ewing's sarcoma .k 1821 to 2350 528 to 5       524/543
(96 %)
0 diff
(100 %id)
AA987962 carcinoid, lung .k 1868 to 2348 480 to 1       480/480
(100 %)
5 diff
(99.0 %id)
DB552582 hippocampus .k 1885 to 2346 1 to 462     Submitted on the opposite strand 462/462
(100 %)
4 diff
(99.2 %id)
AI886365 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 1917 to 2346 429 to 1   tiling clone,   429/429
(100 %)
4 diff
(99.1 %id)
AI872518 adenocarcinoma, Pancreas .k 1977 to 2348 375 to 1       375/375
(100 %)
6 diff
(98.4 %id)
CN271040 embryonic stem cells, DMSO-treated H9 cellline .k 1979 to 2307 329 to 1     Submitted on the opposite strand 329/329
(100 %)
6 diff
(98.2 %id)
AI886060 adenocarcinoma, Pancreas .k 2056 to 2348 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AA804710 liposarcoma .k 2098 to 2361 1 to 264       264/270
(97 %)
8 diff
(97.1 %id)
AL567240 brain, fetal brain .k 2100 to 2320 232 to 1       810/933
(86 %)
32 diff
(96.6 %id)
BP418753 small intestine .k 2126 to 2350 1 to 225     Submitted on the opposite strand 225/225
(100 %)
4 diff
(98.3 %id)
BQ050637 leiomyosarcoma, uterus .k 2297 to 3114 1 to 820   tiling clone,   820/1029
(79 %)
6 diff
(99.5 %id)
AL043564 testis .k 2308 to 2754 1 to 447   tiling clone,   447/447
(100 %)
11 diff
(97.6 %id)
BI253236 cervical carcinoma cell line, cervix .k 2317 to 2939 1 to 626       626/629
(99 %)
35 diff
(94.5 %id)
DB013892 esophageal, tumor tissue .k 2446 to 2991 2 to 548   capped   547/547
(100 %)
11 diff
(98.0 %id)
TI_57161966   .k 2521 to 3307 28 to 817       790/818
(96 %)
22 diff
(97.4 %id)
BI521551 pooled pancreas and spleen .k 2526 to 3161 1 to 640       640/642
(99 %)
18 diff
(97.2 %id)
BI832614 pooled pancreas and spleen .k 2526 to 3307 1 to 785       785/786
(99 %)
20 diff
(97.5 %id)
BG389499 embryonal carcinoma, cell line, testis .k 2607 to 3247 1 to 639       639/639
(100 %)
4 diff
(99.4 %id)
DA644840   .k 2721 to 3299 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BF036855 adenocarcinoma, ovary .k 2771 to 3397 1 to 624       624/624
(100 %)
5 diff
(99.2 %id)
BG681520 skin, squamous cell carcinoma .k 2882 to 3763 1 to 876       876/963
(90 %)
22 diff
(97.8 %id)
BF030241 hypernephroma, Kidney .k 3063 to 3656 601 to 1     Submitted on the opposite strand 601/852
(70 %)
45 diff
(94.8 %id)
AV725976 hypothalamus .k 3141 to 3907 1 to 765       765/765
(100 %)
21 diff
(97.3 %id)
BF211018 bone marrow, from chronic myelogenous leukemia .k 3227 to 3866 641 to 1     Submitted on the opposite strand 641/872
(73 %)
39 diff
(95.6 %id)
BQ423692 embryonal carcinoma, cell line, testis .k 3281 to 3986 1 to 712       712/876
(81 %)
14 diff
(98.5 %id)
CN280338 embryonic stem cells, DMSO-treated H9 cellline .k 3283 to 3889 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
BF033050 adenocarcinoma, ovary .k 3340 to 4036 1 to 677       677/889
(76 %)
32 diff
(96.5 %id)
BG290953 bladder, transitional cell papilloma, cell line .k 3429 to 4148 1 to 716       716/984
(72 %)
35 diff
(96.5 %id)
CN280339 embryonic stem cells, DMSO-treated H9 cellline .k 3520 to 4112 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
AA984166 schizophrenic brain S-11 frontal lobe .k 3557 to 4203 1 to 656     Submitted on the opposite strand 656/730
(89 %)
43 diff
(94.2 %id)
BG431802 Kidney .k 3577 to 4464 1 to 891       891/1036
(86 %)
77 diff
(92.6 %id)
AA348460 brain, hippocampus .k 3768 to 4041 1 to 274       274/274
(100 %)
0 diff
(100 %id)
AW956840   .k 3769 to 4389 1 to 617       617/617
(100 %)
19 diff
(97.0 %id)
BM012368 brain, neuroblastoma, cell line .k 3775 to 4552 1 to 782   tiling clone,   782/782
(100 %)
17 diff
(97.9 %id)
TI_59381579   .k 3776 to 4552 103 to 883       781/781
(100 %)
16 diff
(98.0 %id)
BF238827 bone marrow, from chronic myelogenous leukemia .k 3851 to 4447 1 to 594       594/748
(79 %)
42 diff
(94.4 %id)
BP422802 small intestine .k 3921 to 4431 1 to 510     Submitted on the opposite strand 510/510
(100 %)
3 diff
(99.5 %id)
BG028946 Bone, osteosarcoma, cell line .k 3921 to 4691 1 to 758       758/918
(82 %)
37 diff
(96.0 %id)
BU686631 lung, Primary Lung Epithelial Cells .k 3955 to 4644 1 to 690     Submitted on the opposite strand 690/690
(100 %)
4 diff
(99.5 %id)
BU686655 lung, Primary Lung Epithelial Cells .k 3955 to 4636 1 to 682     Submitted on the opposite strand 682/682
(100 %)
1 diff
(99.9 %id)
AA535746 invasive prostate tumor, Prostate .k 4040 to 4461 1 to 421       421/421
(100 %)
8 diff
(98.1 %id)
AA533380 invasive prostate tumor, Prostate .k 4045 to 4500 7 to 460       454/523
(86 %)
39 diff
(92.6 %id)
AI821513 invasive prostate tumor, Prostate .k 4045 to 4472 8 to 435       428/435
(98 %)
6 diff
(98.7 %id)
AI821488 invasive prostate tumor, Prostate .k 4045 to 4475 8 to 438       431/438
(98 %)
6 diff
(98.7 %id)
BP421978 small intestine .k 4051 to 4564 1 to 514     Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
AV700602 hepatocellular carcinoma .k 4059 to 4802 746 to 1       746/748
(99 %)
32 diff
(95.8 %id)
AA056387 colon, tumor .k 4093 to 4478 1 to 387   tiling clone, Submitted on the opposite strand 387/387
(100 %)
4 diff
(99.0 %id)
BG677119 skin, squamous cell carcinoma .k 4094 to 4823 1 to 728       728/922
(78 %)
16 diff
(98.3 %id)
BM315101 Pancreas, Purified pancreatic islet .k 4135 to 4645 17 to 527       511/527
(96 %)
6 diff
(98.9 %id)
BG705328 brain, hippocampus .k 4146 to 4829 1 to 684   available from MGC,   684/708
(96 %)
15 diff
(97.9 %id)
BC031860 Brain, hippocampus .k 4150 to 4819 11 to 680   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 670/672
(99 %)
2 diff
(99.8 %id)
CK825100 Pancreas, Purified pancreatic islet .k 4176 to 4726 1 to 551     Submitted on the opposite strand 551/551
(100 %)
1 diff
(99.9 %id)
T88845 liver and spleen .k 4201 to 4615 427 to 1     Submitted on the opposite strand 427/431
(99 %)
16 diff
(96.3 %id)
AI769751 2 pooled tumors (clear cell type), Kidney .k 4281 to 4815 535 to 1       535/535
(100 %)
5 diff
(99.1 %id)
TI_149281804   .k 4287 to 4999 796 to 90   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 707/709
(99 %)
11 diff
(98.5 %id)
FN082147 breast carcinoma .k 4304 to 4359 1 to 56       56/57
(98 %)
1 diff
(98.3 %id)
AI890125 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 4304 to 4814 511 to 1       511/511
(100 %)
0 diff
(100 %id)
BG499618 adenocarcinoma, Prostate .k 4308 to 4821 1 to 520       520/723
(71 %)
8 diff
(98.9 %id)
BM983509 lung .k 4309 to 4999 703 to 16   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 688/688
(100 %)
8 diff
(98.9 %id)
CK825101 Pancreas, Purified pancreatic islet .k 4337 to 4829 514 to 22     Submitted on the opposite strand 493/514
(95 %)
5 diff
(99.1 %id)
AI797291 pooled .k 4338 to 4816 481 to 3       479/481
(99 %)
0 diff
(100 %id)
AA534692 colon .k 4358 to 4822 466 to 1       466/466
(100 %)
5 diff
(99.0 %id)
BX089687 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 4364 to 4814 465 to 15   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
AA877133 Kidney .k 4364 to 4814 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AA056501 colon, tumor .k 4397 to 4815 420 to 1     Submitted on the opposite strand 420/420
(100 %)
3 diff
(99.3 %id)
AA600344   .k 4405 to 4814 438 to 30   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
AI300465 carcinoid, lung .k 4407 to 4814 433 to 26   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 408/408
(100 %)
1 diff
(99.8 %id)
AI376117   .k 4415 to 4814 411 to 12   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 400/400
(100 %)
0 diff
(100 %id)
AI376622 pooled .k 4421 to 4814 409 to 16   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
AI791654 invasive prostate tumor, Prostate .k 4425 to 4816 410 to 19       392/410
(95 %)
0 diff
(100 %id)
BX506179   .k 4433 to 5013 590 to 10   tiling clone, Submitted on the opposite strand 581/590
(98 %)
0 diff
(100 %id)
AI655898 pooled germ cell tumors .k 4439 to 4806 377 to 10       368/377
(97 %)
0 diff
(100 %id)
D29031 epidermis .k 4448 to 4724 1 to 275       275/287
(95 %)
11 diff
(96.2 %id)
AW118107 pooled .k 4455 to 4821 387 to 20   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 368/368
(100 %)
0 diff
(100 %id)
AI791633 invasive prostate tumor, Prostate .k 4505 to 4816 330 to 19       312/330
(94 %)
0 diff
(100 %id)
AI961311 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 4512 to 4822 332 to 20       313/332
(94 %)
0 diff
(100 %id)
CA397653 eye, RPE/choroid .k 4519 to 4814 12 to 307   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 296/307
(96 %)
6 diff
(98.1 %id)
BP418549 small intestine .k 4563 to 4820 2 to 257     Submitted on the opposite strand 256/263
(97 %)
3 diff
(98.9 %id)
BP420709 small intestine .k 4597 to 4816 1 to 220     Submitted on the opposite strand 220/222
(99 %)
1 diff
(99.6 %id)
AA348459 brain, hippocampus .k 4619 to 4814 196 to 1       196/196
(100 %)
0 diff
(100 %id)
AI926428 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k 4670 to 4816 147 to 1       147/152
(96 %)
4 diff
(97.4 %id)
AI872896 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 4682 to 5003 324 to 2   tiling clone,   323/324
(99 %)
0 diff
(100 %id)
T25160   .k 4707 to 4822 118 to 3       116/118
(98 %)
0 diff
(100 %id)
AI970761 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .l-u 1 to 454 454 to 1 N76S F98L K108P L111V tiling clone,   454/454
(100 %)
5 diff
(98.9 %id)
BE772997 prostate_tumor .m 1 to 342 1 to 343 S4K S36* tiling clone,   343/343
(100 %)
4 diff
(98.9 %id)
BE773024 prostate_tumor .m 1 to 330 333 to 1   tiling clone,   333/333
(100 %)
5 diff
(98.5 %id)
AI990294 pooled germ cell tumors .n 1 to 472 473 to 1   tiling clone,   473/473
(100 %)
5 diff
(99.0 %id)
BI753032 brain .n 354 to 532 1 to 180       180/180
(100 %)
2 diff
(98.9 %id)
AK094930 corpus callosum .n 358 to 2688 1 to 2330 exact tiling clone, available from FLJ,   2330/2330
(100 %)
10 diff
(99.6 %id)
DA282278 corpus callosum .n 359 to 925 2 to 569 exact capped   568/569
(99 %)
2 diff
(99.7 %id)
BG535486 lung .n 379 to 1079 1 to 704 K76N E77G M78N I79D P80T ...     704/727
(96 %)
15 diff
(98.0 %id)
BF967170 brain, hypothalamus .n 395 to 1081 1 to 688 exact     688/688
(100 %)
7 diff
(99.0 %id)
BG706539 brain, hypothalamus .n 395 to 1048 1 to 654 exact     654/654
(100 %)
3 diff
(99.6 %id)
BG187143   .n 534 to 1375 841 to 12     Submitted on the opposite strand 830/882
(94 %)
35 diff
(96.1 %id)
BG182446   .n 543 to 1357 1 to 811       811/812
(99 %)
17 diff
(98.0 %id)
BG194813   .n 543 to 1369 1 to 821       821/876
(93 %)
20 diff
(97.8 %id)
BG208905   .n 543 to 1351 1 to 803       803/806
(99 %)
23 diff
(97.2 %id)
BG212144   .n 543 to 1382 1 to 834       834/889
(93 %)
41 diff
(95.4 %id)
BG213087   .n 543 to 1345 1 to 802   tiling clone,   802/803
(99 %)
8 diff
(99.1 %id)
BG191848   .n 591 to 1442 856 to 14     Submitted on the opposite strand 844/906
(93 %)
28 diff
(97.0 %id)
BF967901 brain, hypothalamus .n 1993 to 2644 659 to 16   tiling clone,   644/1018
(63 %)
0 diff
(100 %id)
DB307370 corpus callosum .n 2144 to 2688 545 to 1       545/545
(100 %)
8 diff
(98.6 %id)
BF926604 nervous_tumor .o 1 to 252 262 to 13 K44Q L82T R83D tiling clone, Submitted on the opposite strand 250/288
(86 %)
3 diff
(99.0 %id)
AI634423 pooled germ cell tumors .p 1 to 597 1 to 597 exact tiling clone, Submitted on the opposite strand 597/597
(100 %)
1 diff
(99.9 %id)
AW450040   .p 2 to 400 1 to 399     Submitted on the opposite strand 399/399
(100 %)
3 diff
(99.3 %id)
AA300181 uterus .q 1 to 331 1 to 332   tiling clone,   332/332
(100 %)
3 diff
(99.1 %id)
AW959579   .q 2 to 571 1 to 572 exact tiling clone,   572/575
(99 %)
16 diff
(97.3 %id)
AI298166 carcinoid, lung .r 1 to 374 374 to 1 exact tiling clone,   374/374
(100 %)
0 diff
(100 %id)
DA370427 thalamus .s 1 to 538 2 to 539 exact tiling clone, capped   538/546
(98 %)
1 diff
(99.9 %id)
BX503857   .t-u 1 to 679 1 to 679   tiling clone,   679/679
(100 %)
0 diff
(100 %id)
BG540760 lung .t-u 92 to 751 1 to 660   tiling clone,   660/802
(82 %)
25 diff
(96.9 %id)
BI093272 cervix .t-u 139 to 873 1 to 734   tiling clone,   734/734
(100 %)
4 diff
(99.5 %id)
CK300903 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .t-u 691 to 1378 716 to 28 exact tiling clone,   689/736
(93 %)
0 diff
(100 %id)
TI_151734627   .t-u 691 to 1378 783 to 95 exact     689/1044
(65 %)
0 diff
(100 %id)
BG210581   .t-u 716 to 1387 684 to 14 exact   Submitted on the opposite strand 671/770
(87 %)
0 diff
(100 %id)
CF142838 lymph .t-u 724 to 1373 657 to 8 exact   Submitted on the opposite strand 650/657
(98 %)
0 diff
(100 %id)
BG187144   .t-u 729 to 1377 672 to 24 exact   Submitted on the opposite strand 649/864
(75 %)
0 diff
(100 %id)
BX091900 placenta .t-u 734 to 1405 687 to 15 T14X AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 673/673
(100 %)
3 diff
(99.6 %id)
BG202622   .t-u 858 to 1455 600 to 8 E2V C3*   Submitted on the opposite strand 593/870
(68 %)
0 diff
(100 %id)
AA716413 heart .t-u 898 to 1391 494 to 1 exact     494/494
(100 %)
1 diff
(99.8 %id)
AW197193 pooled germ cell tumors .t-u 914 to 1390 477 to 1 exact     477/477
(100 %)
1 diff
(99.8 %id)
BG213088   .t-u 919 to 1455 543 to 7 E2S C3E S4V V5L F6S ...   Submitted on the opposite strand 537/829
(64 %)
0 diff
(100 %id)
AA702611 pineal gland .t-u 985 to 1378 405 to 12   AAA   394/394
(100 %)
0 diff
(100 %id)
R77019 placenta .t-u 1000 to 1379 391 to 1     Submitted on the opposite strand 391/414
(94 %)
20 diff
(95.2 %id)
BG181932   .t-u 1034 to 1368 340 to 7     Submitted on the opposite strand 334/344
(97 %)
0 diff
(100 %id)
AI039443   .t-u 1044 to 1462 429 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
BG188195   .t-u 1054 to 1391 346 to 9     Submitted on the opposite strand 338/346
(97 %)
0 diff
(100 %id)
R32936 placenta .t-u 1083 to 1405 332 to 1     Submitted on the opposite strand 332/365
(90 %)
20 diff
(94.6 %id)
R79624 placenta .t-u 1085 to 1379 306 to 1     Submitted on the opposite strand 306/308
(99 %)
16 diff
(94.9 %id)
BG209463   .t-u 1125 to 1389 275 to 11     Submitted on the opposite strand 265/275
(96 %)
0 diff
(100 %id)
AW183412 pooled .t-u 1150 to 1472 326 to 4       323/326
(99 %)
0 diff
(100 %id)
AA868145   .t-u 1196 to 1460 266 to 2       265/266
(99 %)
0 diff
(100 %id)
BG163572 hypernephroma, cell line, Kidney .u 1 to 652 1 to 657 exact tiling clone,   657/673
(97 %)
9 diff
(98.7 %id)
BG926780 cartilage .u 58 to 642 86 to 670 exact tiling clone,   585/617
(94 %)
9 diff
(98.6 %id)
TI_227715102   .u 370 to 1137 852 to 92   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 761/966
(78 %)
12 diff
(98.8 %id)
CD365598 Alveolar Macrophage, lung .u 420 to 1137 731 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 715/717
(99 %)
6 diff
(99.2 %id)
BX110469 liver and spleen .va 1 to 699 1 to 699 exact tiling clone,   699/699
(100 %)
2 diff
(99.8 %id)
AA002238 liver and spleen .va 2 to 474 1 to 476 D24G W25L E26G S27E F28L ... fully sequenced,   476/476
(100 %)
4 diff
(99.2 %id)
AA002077 liver and spleen .va 444 to 886 454 to 1   tiling clone, fully sequenced,   454/454
(100 %)
13 diff
(97.2 %id)
DA102207 cerebellum .vb-u 1 to 594 2 to 595   tiling clone, capped   594/594
(100 %)
1 diff
(99.9 %id)
T59185 fetal spleen, Spleen .vb-u 45 to 398 1 to 362       362/363
(99 %)
11 diff
(97.0 %id)
AW511632 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vb-u 359 to 843 486 to 1 S18F T19Y L20I K21E F22V ... tiling clone,   486/486
(100 %)
1 diff
(99.8 %id)
T59147 fetal spleen, Spleen .vb-u 438 to 828 396 to 1 F2X N30X H34X tiling clone,   396/398
(99 %)
11 diff
(97.3 %id)
AW129382 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vb-u 463 to 816 359 to 5 S18F T19Y L20I K21E F22V ...     355/359
(98 %)
0 diff
(100 %id)
BG185563   .vc 1 to 332 13 to 344       332/344
(96 %)
11 diff
(96.9 %id)
BG197972   .vc 1 to 786 13 to 794 exact tiling clone,   782/796
(98 %)
31 diff
(96.2 %id)
BG199544   .vc 1 to 230 38 to 267 exact     791/833
(94 %)
43 diff
(94.9 %id)
BG202621   .vc 1 to 592 13 to 605 exact tiling clone,   593/805
(73 %)
42 diff
(94.8 %id)
AW852358 colon .vd-u 1 to 366 369 to 4   tiling clone,   366/369
(99 %)
0 diff
(100 %id)
BE537689 cervix .vd-u 190 to 785 1 to 606 Y20I L21F S22K C23L K24Q ... tiling clone,   606/770
(78 %)
20 diff
(97.5 %id)
BG533427 Liver .ve 1 to 687 1 to 706 S2V K11N K12E Q13A K14R ... tiling clone,   706/892
(79 %)
49 diff
(94.6 %id)
BM691836 eye, human retina .vf-u 1 to 624 10 to 633 exact tiling clone,   625/633
(98 %)
6 diff
(99.1 %id)
AW275598 normal squamous epithelium, tongue .vf-u 349 to 630 307 to 26   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 282/282
(100 %)
1 diff
(99.7 %id)
AW082231 pooled .vg 1 to 457 459 to 3 exact tiling clone,   457/459
(99 %)
1 diff
(99.8 %id)
W19171 lung .vh 1 to 439 12 to 453 W25S E26G S27E F28L K29Q ... tiling clone,   442/453
(97 %)
10 diff
(97.8 %id)
BU567610 testis .vh 8 to 367 4 to 363 exact tiling clone,   360/400
(90 %)
8 diff
(98.0 %id)
AW015778   .vi 1 to 394 410 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 393/393
(100 %)
1 diff
(99.8 %id)
AI918913 Prostate .vi 30 to 394 364 to 1       364/543
(67 %)
1 diff
(99.9 %id)
AW468893 pooled .vi 30 to 395 371 to 7   tiling clone,   365/402
(90 %)
0 diff
(100 %id)
AA868045 pooled .vi 135 to 395 267 to 7       261/267
(97 %)
0 diff
(100 %id)
AK226031 small intestine Gene TMEM170AandCFDP1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BE939876 uterus_tumor Gene TMEM170AandCFDP1, variant not shown         Suspected internal deletion, this clone was ignored    
BF743998 breast Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
BX648429 human salivary gland Gene TMEM170AandCFDP1, variant not shown       available from DKFZ, AAA Suspected internal deletion, this clone was ignored    
AL699453 human skeletal muscle Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
AV697389 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, This clone was ignored    
AV699461 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, This clone was ignored    
AV697937 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
AV699972 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
AV700004 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV697969 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV695805 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV699843 hepatocellular carcinoma Gene TMEM170AandCFDP1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored    
BP263283 small intestine Gene TMEM170AandCFDP1, variant not shown         Suspected internal deletion, this clone was ignored    
AA704243 liver and spleen Gene TMEM170AandCFDP1, variant not shown              
AA886982 pooled germ cell tumors Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
AI924420 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
AW080784 esophagus, squamous cell carcinoma Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
BF983309 duodenal adenocarcinoma, cell line, small intestine Gene TMEM170AandCFDP1, variant not shown         Suspected internal deletion, this clone was ignored    
BG402294 Kidney Gene TMEM170AandCFDP1, variant not shown         Suspected internal deletion, this clone was ignored    
BU150970 dorsal root ganglia Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
CX751703 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass Gene TMEM170AandCFDP1, variant not shown         Submitted on the opposite strand    
DB157731 thymus Gene TMEM170AandCFDP1, variant not shown       capped This clone was ignored    
DB346621 thymus Gene TMEM170AandCFDP1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb-u, .vc, .vd-u, .ve, .vf-u, .vg, .vh, .vi Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI